Stephen R Brady - Net Worth and Insider Trading
Stephen R Brady Net Worth
The estimated net worth of Stephen R Brady is at least $609,620 dollars as of 2024-11-29. Stephen R Brady is the EVP, Strategy & Finance of Immune Design Corp and owns about 96,599 shares of Immune Design Corp (IMDZ) stock worth over $565,104. Stephen R Brady is also the President and CEO of Tempest Therapeutics Inc and owns about 46,376 shares of Tempest Therapeutics Inc (TPST) stock worth over $44,516. Details can be seen in Stephen R Brady's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen R Brady has not made any transactions after 2024-07-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen R Brady
Stephen R Brady Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen R Brady owns 2 companies in total, including Atreca Inc (BCEL) , and Tempest Therapeutics Inc (TPST) .
Click here to see the complete history of Stephen R Brady’s form 4 insider trades.
Insider Ownership Summary of Stephen R Brady
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCEL | Atreca Inc | 2021-07-14 | director |
| TPST | Tempest Therapeutics Inc | 2024-07-03 | director & Chief Executive Officer |
Stephen R Brady Latest Holdings Summary
Stephen R Brady currently owns a total of 2 stocks. Among these stocks, Stephen R Brady owns 96,599 shares of Immune Design Corp (IMDZ) as of January 7, 2019, with a value of $565,104 and a weighting of 92.7%. Stephen R Brady also owns 46,376 shares of Tempest Therapeutics Inc (TPST) as of July 3, 2024, with a value of $44,516 and a weighting of 7.3%.
Latest Holdings of Stephen R Brady
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IMDZ | Immune Design Corp | 2019-01-07 | 96,599 | 5.85 | 565,104 |
| TPST | Tempest Therapeutics Inc | 2024-07-03 | 46,376 | 0.96 | 44,516 |
Holding Weightings of Stephen R Brady
Stephen R Brady Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen R Brady has made a total of 0 transactions in Immune Design Corp (IMDZ) over the past 5 years. The most-recent trade in Immune Design Corp is the sale of 5,516 shares on January 7, 2019, which brought Stephen R Brady around $8,715.
According to the SEC Form 4 filings, Stephen R Brady has made a total of 1 transactions in Tempest Therapeutics Inc (TPST) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tempest Therapeutics Inc is the acquisition of 35,000 shares on July 3, 2024, which cost Stephen R Brady around $73,850.
Insider Trading History of Stephen R Brady
- 1
Stephen R Brady Trading Performance
GuruFocus tracks the stock performance after each of Stephen R Brady's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen R Brady is -14.58%. GuruFocus also compares Stephen R Brady's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen R Brady within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen R Brady's insider trading performs compared to the benchmark.
Performance of Stephen R Brady
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.73 | | | | | |
| Relative Return to S&P 500(%) | -8.66 | | | | | |
Stephen R Brady Ownership Network
Stephen R Brady Owned Company Details
What does Atreca Inc do?
Who are the key executives at Atreca Inc?
Stephen R Brady is the director of Atreca Inc. Other key executives at Atreca Inc include director & Chief Strategy Officer Tito Serafini , other: Former 10% Owner Felix Baker , and other: Former 10% Owner Baker Bros. Advisors Lp .
Atreca Inc (BCEL) Insider Trades Summary
Over the past 18 months, Stephen R Brady made no insider transaction in Atreca Inc (BCEL). Other recent insider transactions involving Atreca Inc (BCEL) include a net sale of 34,668 shares made by Tito Serafini , a net sale of 11,137 shares made by Phillips Courtney , and a net sale of 274,739 shares made by Baker Bros. Advisors Lp .
In summary, during the past 3 months, insiders sold 0 shares of Atreca Inc (BCEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 353,058 shares of Atreca Inc (BCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,058 shares.
Atreca Inc (BCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atreca Inc Insider Transactions
Stephen R Brady Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen R Brady. You might contact Stephen R Brady via mailing address: C/o Immune Design Corp., 1616 Eastlake Ave. E, Suite 310, Seattle Wa 98102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
